ジャナックス・セラピューティクスに関するコメント

$サンシャイン・バイオファーマ(SBFM.US)$$ジャナックス・セラピューティクス(JANX.US)$ time

Hello Mooers!
A quick recap for the month ending April 30, 2024.
Ten stocks with >300% YTD
$SWVLホールディングス(SWVL.US)$718.40%
$ルート(ROOT.US)$564.60%
$エレベーション・オンコロジー(ELEV.US)$561.08%
$ジャンワン(JAN.US)$554.05%
$GENEDXホールディングス(WGS.US)$520.71%
$コーバスファーマシューティカルズホールディングス(CRBP.US)$513.25%
$AGBAアクイジション(AGBA.US)$482.90%
$ジャナックス・セラピューティクス(JANX.US)$431.22%
$デイブ(DAVE.US)$4...

RECAP
The $NYダウ(.DJI.US)$ shed some 500 points and the $S&P 500 Index(.SPX.US)$ and $Nasdaq Composite Index(.IXIC.US)$ both fell more than 1% Friday as Dow components JPMorgan Chase and Intel dragged the market lower.
The DJIA shed 470.78 points (1.2%) to a preliminary 37988.3 closer, while the $S&P 500 Index(.SPX.US)$ gave up 75.46 ticks (1.5%) to a tentative 5,123.6 finish.
Meanwhile, the $Nasdaq Composite Index(.IXIC.US)$ -- which ...

$ジャナックス・セラピューティクス(JANX.US)$ shares climbed for a fifth straight session, poised for a 45% gain this week, after Bloomberg reported that the drugmaker is exploring options, including a potential sale, after receiving takeover interest from larger pharmaceutical companies.
The company, which develops tumor-activated immunotherapies to treat cancer, is working with a financial adviser to evaluate possibilities including a sale, Blo...

$ジャナックス・セラピューティクス(JANX.US)$ rallied more than 10% for the second straight session Thursday as investors continued to bid up the biotech amid a report that the company might be up for sale.
JANX rose 12.1% to $50 a share one day after gaining 11.5% on Wednesday following a Bloomberg News report about the potential sale of the firm, which develops anti-cancer drugs.
The news service cited unnamed sources as saying that Janu...

$ジャナックス・セラピューティクス(JANX.US)$ should i sell now

RECAP
The $NYダウ(.DJI.US)$ fell more than 400 points Wednesday, while the $S&P 500 Index(.SPX.US)$ and $Nasdaq Composite Index(.IXIC.US)$ sank nearly 1% after a stronger-than-expected March inflation report dampened hopes for Federal Reserve interest-rate cuts.
The Dow shed 422.16 points (1.1%) to a 38,461.51 close, while S&P 500 gave up 49.27 ticks (1%) to 5,160.61 and the $Nasdaq Composite Index(.IXIC.US)$ dropped 1...

$ジャナックス・セラピューティクス(JANX.US)$ Drugmaker Janux Therapeutics Said To Weigh Possible Sale"

$ジャナックス・セラピューティクス(JANX.US)$
DONT HOLD OVER THE WEEKEND!!!

$ジャナックス・セラピューティクス(JANX.US)$ it's going down 😂, my puts printing 💪